{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:58:18Z","timestamp":1781819898065,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.neurobiolaging.2003.12.024","type":"journal-article","created":{"date-parts":[[2004,5,8]],"date-time":"2004-05-08T11:37:11Z","timestamp":1084016231000},"page":"651-660","source":"Crossref","is-referenced-by-count":87,"title":["Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"25","author":[{"given":"Debomoy K.","family":"Lahiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sambamurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/hmg\/7.12.1887","article-title":"Risk for Alzheimer\u2019s disease correlates with transcriptional activity of the APOE gene","volume":"7","author":"Artiga","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2002-4307","article-title":"Non-familial Alzheimer\u2019s disease is mainly due to genetic factors","volume":"4","author":"Ashford","year":"2002","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-4580(00)00143-3","article-title":"Neuroinflammation and Alzheimer\u2019s disease: critical roles for cytokine\/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E","volume":"21","author":"Bales","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1212\/01.WNL.0000069923.64550.9F","article-title":"Education modifies the relation of AD pathology to level of cognitive function in older persons","volume":"60","author":"Bennett","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/nbdi.1995.0019","article-title":"Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing","volume":"2","author":"Biere","year":"1995","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","article-title":"Apolipoprotein E expression by neurons surviving excitotoxic stress","volume":"6","author":"Boschert","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.ATV.0000043456.48735.20","article-title":"HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells","volume":"23","author":"Dichtl","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1073\/pnas.82.1.203","article-title":"Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets","volume":"82","author":"Elshourbagy","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.277.10.822","article-title":"Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons","volume":"277","author":"Evans","year":"1997","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB11","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/archneur.60.2.185","article-title":"Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status","volume":"60","author":"Evans","year":"2003","journal-title":"Arch. Neurol."},{"issue":"16","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.278.16.1349","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB13","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1523\/JNEUROSCI.16-23-07550.1996","article-title":"Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells","volume":"16","author":"Garcia","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/WNL.56.12.1696","article-title":"Gender and age modify the association between APOE and AD-related neuropathololgy","volume":"56","author":"Ghebremedhin","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/archneur.59.4.594","article-title":"Association between apolipoprotein E genotype and Alzheimer disease in African American subjects","volume":"59","author":"Graff-Radford","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","article-title":"Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain","volume":"21","author":"Grehan","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00002093-200201000-00002","article-title":"Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample","volume":"16","author":"Harwood","year":"2002","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB19","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB20","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to b-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1385\/JMN:23:3:225","article-title":"Apolipoprotein E as a target for developing new therapeutics for Alzheimer\u2019s disease: characterization of the regulatory regions of the apolipoprotein gene","volume":"23","author":"Lahiri","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1749-6632.2002.tb04662.x","article-title":"Functional characterization of the 5\u2032-regulatory region of the murine apolipoprotein gene","volume":"973","author":"Lahiri","year":"2002","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1389450033346957","article-title":"A critical analysis of new molecular targets and strategies for drug developments in Alzheimer\u2019s disease","volume":"4","author":"Lahiri","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jnnp.61.4.352","article-title":"The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer\u2019s disease","volume":"61","author":"Landen","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/JMN:20:3:233","article-title":"Beta-secretase processing of the Alzheimer\u2019s amyloid protein precursor (APP)","volume":"20","author":"Marlow","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0197-4580(01)00223-8","article-title":"Memory performance in healthy elderly without Alzheimer\u2019s disease: effects of time and apolipoprotein-E","volume":"22","author":"Mayeux","year":"2001","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/00001756-200105080-00042","article-title":"Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease","volume":"12","author":"Naidu","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB29","doi-asserted-by":"crossref","first-page":"16114","DOI":"10.1074\/jbc.270.27.16114","article-title":"Novel sequence determinants in peroxisome proliferator signaling","volume":"270","author":"Palmer","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneur.60.1.29","article-title":"Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism","volume":"60","author":"Papassotiropoulos","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB31","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1096\/fj.00-0891fje","article-title":"Convertases other than furin cleave beta-secretase to its mature form","volume":"15","author":"Pinnix","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/bst0260257","article-title":"Role of apolipoprotein E in modulating neurite outgrowth: potential effect of intracellular apolipoprotein E","volume":"26","author":"Pitas","year":"1998","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB33","doi-asserted-by":"crossref","first-page":"122260","DOI":"10.1073\/pnas.92.26.12260","article-title":"Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer\u2019s disease","volume":"92","author":"Poirier","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.2000.0304","article-title":"Hypercholesterolemia accelerates the Alzheimer\u2019s amyloid pathology in a transgenic mouse model","volume":"7","author":"Refolo","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","article-title":"Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease","volume":"47","author":"Roses","year":"1996","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/ana.410420418","article-title":"Apolipoprotein E-associated risk for Alzheimer\u2019s disease in the African-American population is genotype dependent","volume":"42","author":"Sahota","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:1:1:1","article-title":"Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer\u2019s disease","volume":"1","author":"Sambamurti","year":"2002","journal-title":"Neuromol. Med."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0925-4439(00)00035-1","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease: pharmacogenomic target selection","volume":"1502","author":"Saunders","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"41","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB39","doi-asserted-by":"crossref","first-page":"31567","DOI":"10.1074\/jbc.M005468200","article-title":"Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB40","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s004150050351","article-title":"Apolipoprotein E genotype and progression of Alzheimer\u2019s disease: the Rotterdam Study","volume":"246","author":"Slooter","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-1119(98)00337-0","article-title":"Molecular cloning of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein: structural characterization and a comparative study with other species","volume":"217","author":"Song","year":"1998","journal-title":"Gene"},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB42","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid b peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB43","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1046\/j.1471-4159.1998.71041643.x","article-title":"Increased levels of apolipoprotein D in cerebrospinal fluid and hippocampus of Alzheimer\u2019s patients","volume":"71","author":"Terrisse","year":"1998","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, Whites, and Hispanics","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB45","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1096\/fasebj.10.13.8940294","article-title":"Human apolipoprotein E: the Alzheimer\u2019s disease connection","volume":"10","author":"Weisgraber","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB46","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.73.6.672","article-title":"The apolipoprotein E 2 allele and decline in episodic memory","volume":"73","author":"Wilson","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB47","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/archneur.59.7.1154","article-title":"Effect of apolipoprotein E4 allele status on decline in different cognitive systems and development of Alzheimer\u2019s disease over a 6-year period","volume":"59","author":"Wilson","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2003.12.024_BIB48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","article-title":"Specific regional transcription of apolipoprotein E in human brain neurons","volume":"154","author":"Xu","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000051236","article-title":"High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer\u2019s disease","volume":"12","author":"Yamagata","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2003.12.024_BIB50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1997.6709","article-title":"Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning","volume":"149","author":"Zarow","year":"1998","journal-title":"Exp. Neurol."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458004001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T11:33:57Z","timestamp":1623929637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458004001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0197458004001010"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.12.024","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}